Robert W. Baird Begins Coverage on Beta Bionics (NASDAQ:BBNX)
Robert W. Baird initiated coverage on shares of Beta Bionics (NASDAQ:BBNX – Free Report) in a report released on Thursday morning, MarketBeat Ratings reports. The firm issued a neutral rating and a $20.00 target price on the stock. Beta Bionics Stock Down 1.4 % Shares of NASDAQ BBNX opened at $20.57 on Thursday. Beta Bionics […]
